![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/12 | |
A61K 31/415 | |||
A61P 3/04 | |||
C07D 213/72 | |||
A61K 31/444 | |||
A61K 45/06 |
(11) | Number of the document | 2781516 |
(13) | Kind of document | T |
(96) | European patent application number | 13197714.2 |
Date of filing the European patent application | 2011-10-05 | |
(97) | Date of publication of the European application | 2014-09-24 |
(45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
390888 P | 2010-10-07 | US |
(72) |
Sutton, Paul, Allen, US
Girgis, Michael J., US
Liang, Jessica, US
Prashad, Mahavir, US
Villhauer, Edwin, Bernard, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid |
New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid |